Table 1.
Baseline Characteristics of Primary Care Patients With Onset of Glargine or NPH Insulin Therapy (BOT) After Propensity Score Matching.
| Variable | Glargine | NPH | P value |
|---|---|---|---|
| N | 1488 | 1488 | |
| Age (years) | 56.1 (11.8) | 59.1 (11.9) | <.0001 |
| Diabetes duration (years) | 6.4 (4.1) | 5.5 (3.7) | <.0001 |
| Males (%) | 53.2 | 53.7 | .7970 |
| Region (western Germany) (%) | 70.9 | 78.8 | <.0001 |
| Diabetologist care (%) | 15.9 | 16.2 | .8417 |
| Disease management program (%) | 70.4 | 69.4 | .5490 |
| Number of different oral antidiabetic drugs (baseline) | 1.4 (0.6) | 1.4 (0.6) | .4486 |
| Last HbA1c (%) (baseline) | 8.8 (1.6) | 8.5 (1.6) | <.0001 |
| Charlson Comorbidity Index | 2.1 (1.5) | 2.0 (1.4) | .4960 |
Patients were propensity score matched (variables in the table excluding HbA1c, disease management program, and region). Data are means (SD) or proportions (%).